Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice
Apart from the potent GH-releasing action, ghrelin has other actions including stimulation of lactotroph and corticotroph function, influence on the pituitary gonadal axis, stimulation of appetite, control of energy balance, influence on sleep and behavior, control of gastric motility and acid secretion, influence on exocrine and endocrine pancreatic function as well as on glucose metabolism, cardiovascular actions and modulation of proliferation of neoplastic cells, as well as of the immune system
And theres no official policy recommendation from the American Academy of Pediatrics (at least not yet)
Medicare Part D coverage for Wegovy (oral and injectable) begins January 2027, with an interim program starting July 2026
But if you want side effects connected to the GLP-1 routine, MeAgain is the better default